TRAIL-receptor and proteasome targeted therapies in non-small cell lung cancer
PhD ceremony: Ms. J.H. Stegehuis, 13.15 uur, Academiegebouw, Broerstraat 5, Groningen
Title: TRAIL-receptor and proteasome targeted therapies in non-small cell lung cancer
Promotor(s): prof. E.G.E. de Vries
Faculty: Medical Sciences
The natural occurring protein TRAIL is important in the battle against cancer. TRAIL binds to healthy cells where it but does not cause damage, whereas binding to tumour cells may lead to their elimination. Various TRAIL-receptor targeting drugs are likely to increase the activity of anticancer drugs, as has been shown in preclinical studies. The aim of this thesis was to explore the combined use of TRAIL-receptor targeting therapies with the anticancer drug bortezomib in preclinical models of non-small cell lung cancer. It was found that the combination strongly induces apoptosis. Bortezomib could overcome tumour cell preferences for TRAIL-receptor1 or TRAIL-receptor2 apoptosis and enhance apoptosis induced via both receptors in the cancer cells. Examination of the underlying mechanisms revealed that bortezomib could sensitize TRAIL-induced apoptosis at the level of DISC (at the membrane) as well as at the level of the mitochondria (intracellular). Bortezomib had an effect on TRAIL-receptor endocytosis, although its functionality remains unknown.
Last modified: | 13 March 2020 01.12 a.m. |
More news
-
08 May 2025
KNAW appoints three professors of UG/UMCG as new members
Professors Jingyuan Fu, Lisa Herzog, and Helga de Valk of the UG have been appointed members by the Royal Netherlands Academy of Arts and Sciences (KNAW).
-
06 May 2025
Science for Society | Exercise-based learning improves children’s skills
Teaching primary school children language and maths through exercise improves their attention and task orientation. Jumping and jogging for half an hour, three times a week, while absorbing the teaching material, improves test results.
-
14 April 2025
12 Marie Sklodowska Curie Doctoral Networks for the University of Groningen
The University of Groningen has achieved very good results in the last round of Marie Sklodowska Curie Doctoral Networks.